Ablation Technology Market Growing at a CAGR of 9.3% - Research Provides Detailed Analysis of Trends, Growth and Forecast
In January 2021, AtriCure announced FDA approval for expanding labeling claims for cryo nerve block (cryoNB) therapy to include the treatment of adolescent patients (12-21 years of age).
View full press release